Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 11—November 2004


Evaluating Human Papillomavirus Vaccination Programs

Al V. Taira*, Christopher P. Neukermans†, and Gillian D. Sanders†‡Comments to Author 
Author affiliations: *Stanford School of Medicine, Stanford, California, USA; †Stanford University, Stanford, California, USA; ‡Duke University, Durham, North Carolina, USA

Main Article

Table 3

Reduction in lifetime risk of cervical cancer

Cohort % reduction in lifetime
risk of cervical cancer
Full potential of program in 12-year-old girls 64
First cohort of 12-year-old girls vaccinateda 46
24-year-old women who receive catch-up vaccinationb 35
30-year-old women who receive catch-up vaccinationb 17

aThis group experiences a lower reduction in cancer cases because many of their sex partners will be drawn from a population pool that has not been vaccinated.
b24- or 30-year-old women who opt for catch-up vaccination in the first year that the vaccine becomes available.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO